Literature DB >> 33692091

Tocilizumab for hospitalized patients with COVID-19.

Kevin Afra1, Luke Y C Chen2, David Sweet2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33692091     DOI: 10.1503/cmaj.210066

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  1 in total

1.  Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study.

Authors:  Sophie Stukas; George Goshua; Angus Kinkade; Rebecca Grey; Gregory Mah; Catherine M Biggs; Shahin Jamal; Sonny Thiara; Tim T Y Lau; Jolanta Piszczek; Nilu Partovi; David D Sweet; Agnes Y Y Lee; Cheryl L Wellington; Mypinder S Sekhon; Luke Y C Chen
Journal:  Lancet Reg Health Am       Date:  2022-03-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.